SOW
STLN

State of Wyoming’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

State of Wyoming’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$318K Sell
103,617
-3,056
-3% -$9.37K 0.04% 638
2025
Q4 		$380K Buy
106,673
+43,688
+69% +$162K 0.04% 560
2025
Q3 		$220K Buy
62,985
+44,937
+249% +$154K 0.03% 872
2025
Q2 		$37K Buy
+18,048
New +$45.1K ﹤0.01% 1630
2022
Q2 		– Sell
-967
Closed -$7K – 2138
2022
Q1 		$7K Buy
+967
New +$6.52K ﹤0.01% 1642

Other funds holding STLN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.88% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State of Wyoming's STLN Position: Q1 2026 in Review

State of Wyoming reduced its Starling Oncology Institute, Inc. Common Stock (STLN) stake by 2.9% in Q1 2026, selling an estimated $9.37K and leaving 103,617 shares worth $318K. The position accounts for 0.04% of the portfolio, ranked #638.

State of Wyoming first reported a position in STLN in Q1 2022 and has held it in 5 quarters since. The position peaked at $380K in Q4 2025. 115 funds tracked by Wall St. Rank hold STLN as of Q1 2026.

  • State of Wyoming held 103,617 shares of Starling Oncology Institute, Inc. Common Stock worth $318K as of Q1 2026.
  • State of Wyoming sold 3,056 Starling Oncology Institute, Inc. Common Stock shares in Q1 2026, an estimated $9.37K.
  • Starling Oncology Institute, Inc. Common Stock made up 0.04% of State of Wyoming's portfolio in Q1 2026, its #638 holding.
  • State of Wyoming first reported a position in Starling Oncology Institute, Inc. Common Stock in Q1 2022 and has held it in 5 quarters since.
  • State of Wyoming's Starling Oncology Institute, Inc. Common Stock position peaked at $380K in Q4 2025.
  • 115 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q1 2026.

Based on State of Wyoming's 13F filing for Q1 2026, filed 13 May 2026.